Myo E, Mohandas C. Comparison of subcutaneous GLP-1 receptor agonists, semaglutide and dulaglutide, on HbA1c and weight loss outcomes: A systematic review. AJPP [Internet]. 2025 Jun. 19 [cited 2026 Apr. 28];5(1):45-6. Available from: https://journals.kent.ac.uk/index.php/ajpp/article/view/1365